A downregulation of TMIGD1 in inflammatory conditions has been identified in a systematic transcriptomic analysis of mRNA expression levels in inflamed tissue vs uninflamed tissue in patients suffering from Crohns Disease (CD), which is a subtype of inflammatory bowel disease (IBD) characterized by chronic intestinal inflammation [76]. This evidence concerns the gene TMIGD1 and inflammatory bowel disease.